2009 Mar Nazzareno Ballatori, Suzanne M Krance, Sylvia Notenboom, Shujie Shi, Kim Tieu, Christine L Hammond
Stay tuned for more expert insights on our upcoming blog posts
GLP-1 receptor agonists are designed to resist rapid enzymatic degradation, thereby allowing sustained receptor activation
Recommended Timing and Dosing Schedule for Retatrutide Retatrutide is given as a once-weekly subcutaneous injection on a consistent chosen day, with dose escalation from a low starting dose up to 12 mg weekly as per trial protocol
Growth hormone secretagogues actually help preserve lean mass, which is why combining a GLP-1 agonist with CJC-1295/ipamorelin is a strategic approach
A personalised plan will be discussed during your consultation